Question:medium
A patient with atrial fibrillation and mitral stenosis presents within 4 hours of symptom onset and is hemodynamically stable. What is the next best step?
A patient with atrial fibrillation and mitral stenosis presents within 4 hours of symptom onset and is hemodynamically stable. What is the next best step?
Show Hint
Recent-onset AF less than 48 hours may be managed with cardioversion if appropriate.
Updated On: May 14, 2026
- Ventricular rate control
- Cardioversion
- Anticoagulation
- Wait and watch
Show Solution
The Correct Option is B
Solution and Explanation
Step 1: Understanding the Question:
The patient has acute AF (< 4 hours) in the setting of structural heart disease (Mitral Stenosis). The priority is to decide between rhythm control and rate control in this high-risk scenario.
Step 2: Detailed Explanation:
Physiology of Mitral Stenosis (MS): In MS, the narrowed valve creates a bottleneck. Ventricular filling depends heavily on "atrial kick" (atrial contraction) and a long diastole. Atrial fibrillation destroys the atrial kick and the resulting tachycardia shortens diastole, leading to acute pulmonary edema.
Acute Management (< 48 hours): If the onset of AF is clearly less than 48 hours (here it is 4 hours), the risk of systemic embolism from cardioversion is low enough that it can be performed immediately without 3 weeks of prior anticoagulation.
Cardioversion (Rhythm Control): Because patients with MS tolerate AF very poorly, the best strategy is to restore sinus rhythm as quickly as possible to stabilize hemodynamics. Even if the patient is currently "stable," they are at extremely high risk of sudden deterioration.
Anticoagulation: While the patient will definitely require long-term anticoagulation (MS + AF = absolute indication), the "next best step" to manage the acute arrhythmia and improve hemodynamics is cardioversion.
Step 3: Final Answer:
Given the acute onset and the critical hemodynamic importance of sinus rhythm in mitral stenosis, Cardioversion is the next best step.
The patient has acute AF (< 4 hours) in the setting of structural heart disease (Mitral Stenosis). The priority is to decide between rhythm control and rate control in this high-risk scenario.
Step 2: Detailed Explanation:
Physiology of Mitral Stenosis (MS): In MS, the narrowed valve creates a bottleneck. Ventricular filling depends heavily on "atrial kick" (atrial contraction) and a long diastole. Atrial fibrillation destroys the atrial kick and the resulting tachycardia shortens diastole, leading to acute pulmonary edema.
Acute Management (< 48 hours): If the onset of AF is clearly less than 48 hours (here it is 4 hours), the risk of systemic embolism from cardioversion is low enough that it can be performed immediately without 3 weeks of prior anticoagulation.
Cardioversion (Rhythm Control): Because patients with MS tolerate AF very poorly, the best strategy is to restore sinus rhythm as quickly as possible to stabilize hemodynamics. Even if the patient is currently "stable," they are at extremely high risk of sudden deterioration.
Anticoagulation: While the patient will definitely require long-term anticoagulation (MS + AF = absolute indication), the "next best step" to manage the acute arrhythmia and improve hemodynamics is cardioversion.
Step 3: Final Answer:
Given the acute onset and the critical hemodynamic importance of sinus rhythm in mitral stenosis, Cardioversion is the next best step.
Was this answer helpful?
0
